BNP Paribas Financial Markets Increases Stock Position in Balchem Co. (NASDAQ:BCPC)

BNP Paribas Financial Markets raised its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 21.5% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 21,356 shares of the basic materials company's stock after acquiring an additional 3,772 shares during the period. BNP Paribas Financial Markets owned approximately 0.07% of Balchem worth $3,759,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in BCPC. William Blair Investment Management LLC grew its position in Balchem by 8.4% during the second quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company's stock valued at $35,998,000 after buying an additional 18,104 shares during the period. Oppenheimer Asset Management Inc. increased its position in Balchem by 22.1% in the second quarter. Oppenheimer Asset Management Inc. now owns 20,582 shares of the basic materials company's stock worth $3,169,000 after buying an additional 3,732 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Balchem by 2.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company's stock valued at $63,707,000 after buying an additional 7,562 shares in the last quarter. Fiera Capital Corp bought a new position in shares of Balchem during the 3rd quarter valued at approximately $4,201,000. Finally, Envestnet Asset Management Inc. increased its holdings in Balchem by 9.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 114,253 shares of the basic materials company's stock worth $17,589,000 after acquiring an additional 10,285 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Balchem Price Performance

BCPC traded down $3.20 on Thursday, hitting $176.38. 89,063 shares of the company's stock traded hands, compared to its average volume of 109,985. The company's 50 day simple moving average is $174.75 and its 200-day simple moving average is $168.07. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. Balchem Co. has a one year low of $127.44 and a one year high of $186.03. The firm has a market cap of $5.73 billion, a price-to-earnings ratio of 47.41, a P/E/G ratio of 5.32 and a beta of 0.67.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on BCPC shares. StockNews.com raised shares of Balchem from a "hold" rating to a "buy" rating in a report on Monday, October 28th. HC Wainwright raised their price objective on shares of Balchem from $185.00 to $190.00 and gave the company a "buy" rating in a research report on Monday, November 4th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.